A

Availability of Evidence for Predictive Machine Learning Algorithms in Primary Care

JAMA Network Open, vol. 7, pp. e2432990

Abstract

Importance: The aging and multimorbid population and health personnel shortages pose a substantial burden on primary health care. While predictive machine learning (ML) algorithms have the potential to address these challenges, concerns include transparency and insufficient reporting of model validation and effectiveness of the implementation in the clinical workflow. Objectives: To systematically identify predictive ML algorithms implemented in primary care from peer-reviewed literature and US Food and Drug Administration (FDA) and Conformité Européene (CE) registration databases and to ascertain the public availability of evidence, including peer-reviewed literature, gray literature, and technical reports across the artificial intelligence (AI) life cycle. Evidence Review: PubMed, Embase, Web of Science, Cochrane Library, Emcare, Academic Search Premier, IEEE Xplore, ACM Digital Library, MathSciNet, AAAI.org (Association for the Advancement of Artificial Intelligence), arXiv, Epistemonikos, PsycINFO, and Google Scholar were searched for studies published between January 2000 and July 2023, with search terms that were related to AI, primary care, and implementation. The search extended to CE-marked or FDA-approved predictive ML algorithms obtained from relevant registration databases. Three reviewers gathered subsequent evidence involving strategies such as product searches, exploration of references, manufacturer website visits, and direct inquiries to authors and product owners. The extent to which the evidence for each predictive ML algorithm aligned with the Dutch AI predictive algorithm (AIPA) guideline requirements was assessed per AI life cycle phase, producing evidence availability scores. Findings: The systematic search identified 43 predictive ML algorithms, of which 25 were commercially available and CE-marked or FDA-approved. The predictive ML algorithms spanned multiple clinical domains, but most (27 [63%]) focused on cardiovascular diseases and diabetes. Most (35 [81%]) were published within the past 5 years. The availability of evidence varied across different phases of the predictive ML algorithm life cycle, with evidence being reported the least for phase 1 (preparation) and phase 5 (impact assessment) (19% and 30%, respectively). Twelve (28%) predictive ML algorithms achieved approximately half of their maximum individual evidence availability score. Overall, predictive ML algorithms from peer-reviewed literature showed higher evidence availability compared with those from FDA-approved or CE-marked databases (45% vs 29%). Conclusions and Relevance: The findings indicate an urgent need to improve the availability of evidence regarding the predictive ML algorithms' quality criteria. Adopting the Dutch AIPA guideline could facilitate transparent and consistent reporting of the quality criteria that could foster trust among end users and facilitating large-scale implementation.

Authors 11

  1. Leiden University · Leiden University Medical Center

    Affiliation as printed

    Department of Public Health and Primary Care, Leiden University Medical Centre, ZA Leiden, the Netherlands

    National eHealth Living Lab, Leiden University Medical Centre, ZA Leiden, the Netherlands

  2. Leiden University Medical Center

    Affiliation as printed

    Department of Information Technology and Digital Innovation, Leiden University Medical Center, ZA Leiden, the Netherlands

  3. HAW Hamburg

    Affiliation as printed

    Hamburg University of Applied Sciences, Department of Health Sciences, Ulmenliet 20, Hamburg, Germany

  4. Utrecht University · University Medical Center Utrecht

    Affiliation as printed

    Department of Digital Health, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, CG Utrecht, the Netherlands

  5. Utrecht University · University Medical Center Utrecht

    Affiliation as printed

    Department of Digital Health, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, CG Utrecht, the Netherlands

  6. Utrecht University · University Medical Center Utrecht

    Affiliation as printed

    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, CG Utrecht, the Netherlands

  7. Utrecht University · University Medical Center Utrecht

    Affiliation as printed

    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, CG Utrecht, the Netherlands

  8. Utrecht University · University Medical Center Utrecht

    Affiliation as printed

    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, CG Utrecht, the Netherlands

  9. Leiden University · Leiden University Medical Center

    Affiliation as printed

    Department of Public Health and Primary Care, Leiden University Medical Centre, ZA Leiden, the Netherlands

    National eHealth Living Lab, Leiden University Medical Centre, ZA Leiden, the Netherlands

  10. Leiden University · Leiden University Medical Center

    Affiliation as printed

    Department of Public Health and Primary Care, Leiden University Medical Centre, ZA Leiden, the Netherlands

    National eHealth Living Lab, Leiden University Medical Centre, ZA Leiden, the Netherlands

  11. Leiden University · Leiden University Medical Center

    Affiliation as printed

    Department of Public Health and Primary Care, Leiden University Medical Centre, ZA Leiden, the Netherlands

    National eHealth Living Lab, Leiden University Medical Centre, ZA Leiden, the Netherlands

Cited by 32 stored of 32

No patents citing this paper on Lens.org (checked 2026-10-11).

References 68